MedTrace Logo

Bilateral and Unilateral Amblyopia Treatment Study

NCT03780205 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2020-08-31

No results posted yet for this study

Summary

The purpose for this study is to investigate spectacle compliance and treatment outcome in bilateral and unilateral refractive amblyopia in children age 3 to \<10 years old. Specifically, how frequently and for what duration is spectacle wear necessary to maximize best-corrected visual acuity by spectacle correction alone.

Conditions

  • Amblyopia

Interventions

OTHER

Prescription glasses for bilateral amblyopia

Correction of refractive error with prescription glasses both eyes

OTHER

Prescription glasses for unilateral amblyopia

Correction of asymmetric refractive errors with lenses

Sponsors & Collaborators

  • Salus University

    lead OTHER

Principal Investigators

  • Stanley Hatch, OD · Salus University

Eligibility

Min Age
3 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-20
Primary Completion
2020-07-07
Completion
2020-07-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03780205 on ClinicalTrials.gov